• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

[LifeVest®心律失常识别算法管理不当致连续致命后果]

[Mismanagement in the arrhythmia recognition algorithm of the LifeVest® with consecutive fatal outcome].

作者信息

Sorleto M, Wuttig H, Aydilek E, Wiemer M

机构信息

Internistische Intensivstation, Johannes Wesling Klinikum Minden, Akademisches Lehrkrankenhaus der medizinischen Hochschule Hannover, Minden, Deutschland.

, Hans-Nolte-Straße 1, 32429, Minden, Deutschland.

出版信息

Herzschrittmacherther Elektrophysiol. 2016 Mar;27(1):57-62. doi: 10.1007/s00399-016-0420-z. Epub 2016 Feb 1.

DOI:10.1007/s00399-016-0420-z
PMID:26830775
Abstract

We describe for the first time the misinterpretation of a wearable cardioverter defibrillator in the arrhythmia recognition algorithm with subsequent fatal outcome of a multi-morbid patient with an ischemic cardiomyopathy and a highly reduced left ventricular pump function (30 %). The patient's death was preceded by a life-threatening shockable rhythm which was repeatedly documented, but ultimately not correctly recognized by the system and therefore not treated.

摘要

我们首次描述了可穿戴式心脏复律除颤器在心律失常识别算法中的误判情况，该误判导致一名患有缺血性心肌病且左心室泵功能严重降低（30%）的多病患者死亡。在患者死亡之前，出现了多次记录的危及生命的可电击心律，但该系统最终未正确识别，因此未进行治疗。

相似文献

1
[Mismanagement in the arrhythmia recognition algorithm of the LifeVest® with consecutive fatal outcome].[LifeVest®心律失常识别算法管理不当致连续致命后果]
Herzschrittmacherther Elektrophysiol. 2016 Mar;27(1):57-62. doi: 10.1007/s00399-016-0420-z. Epub 2016 Feb 1.
2
[Redetection of tachycardia in severe ventricular undersensing].[严重心室感知不足时心动过速的再次检测]
Herzschrittmacherther Elektrophysiol. 2016 Sep;27(3):240-3. doi: 10.1007/s00399-016-0445-3. Epub 2016 Jul 26.
3
A fatal device-device interaction between a wearable automated defibrillator and a unipolar ventricular pacemaker.可穿戴式自动除颤器与单极心室起搏器之间的致命设备-设备相互作用。
Pacing Clin Electrophysiol. 2008 Jul;31(7):912-5. doi: 10.1111/j.1540-8159.2008.01110.x.
4
Repetitive Periodic Atrial Oversensing in a Cardiac Implantable Electrical Defibrillator at 35 Minutes and 50 Minutes Past the Hour: What Is the Diagnosis?心脏植入式心律转复除颤器在整点后35分钟和50分钟出现重复性周期性心房感知过度：诊断是什么？
Pacing Clin Electrophysiol. 2016 Sep;39(9):1018-21. doi: 10.1111/pace.12914. Epub 2016 Jul 26.
5
[Optimisation of subcutaneous defibrillator programming after inappropriate shocks due to new onset of right bundle branch block].[因新发右束支传导阻滞导致不适当电击后皮下除颤器程控的优化]
Herzschrittmacherther Elektrophysiol. 2016 Dec;27(4):399-403. doi: 10.1007/s00399-016-0461-3.
6
Inappropriate shocks or inappropriate programming? A review of Guidant's reconfirmation algorithm.
Europace. 2009 Aug;11(8):1120-2. doi: 10.1093/europace/eup116. Epub 2009 May 13.
7
Wearable cardioverter defibrillators in schools: A guide for parents and educators.学校中的可穿戴式心脏除颤器：家长及教育工作者指南。
Pacing Clin Electrophysiol. 2017 Dec;40(12):1479-1482. doi: 10.1111/pace.13228. Epub 2017 Nov 27.
8
A "shocking" case rectified.一个“令人震惊”的案件得到了纠正。
Pacing Clin Electrophysiol. 2014 Mar;37(3):379-82. doi: 10.1111/pace.12226. Epub 2013 Jul 22.
9
Risk stratification for implantable cardioverter defibrillator therapy: the role of the wearable cardioverter-defibrillator.植入式心脏复律除颤器治疗的风险分层：可穿戴式心脏除颤器的作用。
Eur Heart J. 2013 Aug;34(29):2230-42. doi: 10.1093/eurheartj/eht167. Epub 2013 May 31.
10
Near fatal arrhythmia induction by an implantable cardioverter defibrillator.
J Cardiovasc Electrophysiol. 2006 Sep;17(9):1026-8. doi: 10.1111/j.1540-8167.2006.00532.x. Epub 2006 Jun 9.

本文引用的文献

1
Risk stratification for implantable cardioverter defibrillator therapy: the role of the wearable cardioverter-defibrillator.植入式心脏复律除颤器治疗的风险分层：可穿戴式心脏除颤器的作用。
Eur Heart J. 2013 Aug;34(29):2230-42. doi: 10.1093/eurheartj/eht167. Epub 2013 May 31.
2
ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices): developed in collaboration with the American Association for Thoracic Surgery and Society of Thoracic Surgeons.《美国心脏病学会/美国心脏协会/心律学会2008年心脏节律异常器械治疗指南》：美国心脏病学会/美国心脏协会实践指南工作组（修订ACC/AHA/NASPE 2002年心脏起搏器和抗心律失常器械植入指南更新的写作委员会）报告：与美国胸外科协会和胸外科医师学会合作制定。
Circulation. 2008 May 27;117(21):e350-408. doi: 10.1161/CIRCUALTIONAHA.108.189742. Epub 2008 May 15.
3
Use of a wearable defibrillator in terminating tachyarrhythmias in patients at high risk for sudden death: results of the WEARIT/BIROAD.在猝死高危患者中使用可穿戴式除颤器终止快速心律失常：WEARIT/BIROAD研究结果
Pacing Clin Electrophysiol. 2004 Jan;27(1):4-9. doi: 10.1111/j.1540-8159.2004.00378.x.
4
Clinical efficacy of a wearable defibrillator in acutely terminating episodes of ventricular fibrillation using biphasic shocks.可穿戴式除颤器使用双相电击急性终止心室颤动发作的临床疗效。
Pacing Clin Electrophysiol. 2003 Oct;26(10):2016-22. doi: 10.1046/j.1460-9592.2003.00311.x.